NephSAP: Volume 9


64 1MB The concept of a patient-centered medical home (PCMH) is being advanced by a number of specialty societies and by health care policy experts, as well as by both federal and nonfederal payers.
NephSAP

Volume 9, Number 1, January 2010

Primary Care for the Nephrologist

Denise M. Dupras, MD, PhD and Ericka E. Tung, MD
AMA PRA Category 1 Credits™

The concept of a patient-centered medical home (PCMH) is being advanced by a number of specialty societies and by health care policy experts, as well as by both federal and nonfederal payers....




75 1.2MB As reflected by current guidelines, the main purpose of hypertensive therapy is to prevent or at least alleviate end organ damage (1). Such therapeutic goals are ambitious and need trials that extend for several years with thousands of participants.
NephSAP

Volume 9, Number 2, March 2010

Hypertension

Raymond T. Townsend, MD and Steven C. Textor, MD
AMA PRA Category 1 Credits™

As reflected by current guidelines, the main purpose of hypertensive therapy is to prevent or at least alleviate end organ damage (1). Such therapeutic goals are ambitious and need trials that extend for several years with thousands of participants....




103 0.8MB Nephrology is witnessing a period of critical progress in understanding the biology of a subset of noninflammatory glomerular diseases. As reviewed in this issue of NephSAP, there have been several seminal advances in this field during the past 2 years al
NephSAP

Volume 9, Number 3, May 2010

Glomerular, Vascular, and Tublointerstitial Diseases

Patrick H. Nachman, MD and Richard J. Glassock, MD
AMA PRA Category 1 Credits™

Nephrology is witnessing a period of critical progress in understanding the biology of a subset of noninflammatory glomerular diseases. As reviewed in this issue of NephSAP, there have been several seminal advances in this field during the past 2 years al...




69 1.4MB Very infrequently does a new disease suddenly appear in a group of patients who have been closely observed for the past 30 to 40 years. Nonetheless, this occurred in patients with chronic kidney disease (CKD) and ESRD when nephrogenic systemic fibrosis (N
NephSAP

Volume 9, Number 4, July 2010

Clinical Pharmacology for the Nephrologist

Suzanne Swan, MD, Ali J. Olyaei, Pharm D, BCPS, and Dominic Sica, MD
AMA PRA Category 1 Credits™

Very infrequently does a new disease suddenly appear in a group of patients who have been closely observed for the past 30 to 40 years. Nonetheless, this occurred in patients with chronic kidney disease (CKD) and ESRD when nephrogenic systemic fibrosis (N...




90 9.1MB 1,25-Dihydroxyvitamin D [1,25(OH)2D] is an important hormone with a number of physiologic and pharmacologic effects on mineral homeostasis (classical effects) as well as on immune function; the vasculature; aging; cell differentiation; and other, nonclass
NephSAP

Volume 9, Number 5, September 2010

Disorders of Divalent Ions, Renal Bone Disease, and Nephrolithiasis

Kevin Martin, MBBCh and Stanley Goldfarb, MD
AMA PRA Category 1 Credits™

1,25-Dihydroxyvitamin D [1,25(OH)2D] is an important hormone with a number of physiologic and pharmacologic effects on mineral homeostasis (classical effects) as well as on immune function; the vasculature; aging; cell differentiation; and other, nonclass...




134 1.5MB The new, expanded bundled payment model for outpatient dialysis services is the consequence of a complicated history of payment that has been due for meaningful reform. Historically, dialysis services were largely reimbursed under an adjusted prospective
NephSAP

Volume 9, Number 6, November 2010

End-Stage Renal Disease and Dialysis

Rajiv Agarwal, MD, and Rajnish Mehrotra, MD
AMA PRA Category 1 Credits™

The new, expanded bundled payment model for outpatient dialysis services is the consequence of a complicated history of payment that has been due for meaningful reform. Historically, dialysis services were largely reimbursed under an adjusted prospective ...